Columbia Laboratories (NASDAQ: CBRX) announced that Merck Serono has completed a routine license renewal for CRINONE in one of its ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE